Conflicts of interest in genetic counseling: acknowledging and accepting.
Conflicts of interest in genetic counseling: acknowledging and accepting.
复制标题
遗传咨询中的利益冲突:承认和接受。
DOI:
10.1038/gim.2016.216
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Michie,Marsha
中科院分区:
文献类型:
--
作者:
Stoll,KatieA;Mackison,Amanda;Allyse,MeganA;Michie,Marsha
COMMENTARY alignment with medical professional guidelines. Although practice guidelines are designed to weigh the risks versus benefits of expanding the number of screens and tests offered in the prenatal period—for instance, population-based screening for Fragile X is still not recommended10—commercial testing companies have a stated interest in expanding the number of tests that are ordered. As an employee of the company, a genetic counselor thus has two interests: following practice guidelines and benefiting their employer. These two interests are not always in conflict, but the potential exists. And while commercial laboratories may highlight genetic counseling by a laboratory-provided genetic counselor as a value-added service benefiting patients, it may not always be obvious to patients that they are receiving genetic counseling from an employee of a genetic testing company. Although pretest genetic counseling raises concerns, posttest counseling by industry-employed genetic counselors can also be problematic. Several genetic testing laboratories actively advertise the availability of genetic counseling as an incentive to use their brand of testing. Recipients of these services, however, have called into question whether genetic counselors employed by commercial laboratories are as open to discussing the potential weaknesses and failures of the test as they would be if they were independently employed. Furthermore, promoting ease of genetic counseling to market new genetic tests may promote inappropriate test utilization; providers may be encouraged to order testing beyond their understanding and expertise because they feel they can rely on the laboratory-based genetic counselors to address any issues that may arise. 3 We recognize that genetic counselors employed by laboratories are likely no less focused on providing the best, professionally responsive care than any other genetic counselor, but the reality is that COI exist, regardless of whether they cause clinicians to act against patients’ interests. Furthermore, the discovery of COI after the fact can seriously undermine patients’ trust, not just in an individual genetic counselor but in the entire biomedical infrastructure surrounding genetic testing. A crucial first step is transparency. At the profession-wide level, documentation of the employment status of genetic counselors through the annual status survey should include not only “work setting,” as it now does (http://www. nsgc. org/page/whoaregeneticcounselors), but also the source of employment—in order to reflect the increasing numbers of laboratory-employed genetic counselors who provide direct patient counseling outside of laboratories. This distinction has already been recognized by some insurers, which mandate (and reimburse) genetic counseling only by a non-laboratory employed genetic counselor for certain covered genetic tests. 11 Insurance coverage for genetic counseling may play an increasing role in the employment options of certified genetic counselors as genetic information is increasingly integrated into clinical care.At the individual level, disclosure of financial COI should be mandatory for board-certified genetic counselors in clinical practice, as it is for physicians. Although the Sunshine Act does not provide a legal mandate for such disclosures, it does offer a clear example and a model that could be implemented by the NSGC and/or the certifying body for genetic counselors, the American Board of Genetic Counseling (ABGC). Unfortunately, without the legal mandate this model would require accurate self-reporting by genetic counselors about their COI. The profession would also need to decide how to …